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Abstract 
Interferons represent a major group of the biologic response 
modifiers which exert multipotent effects upon cell growth, cyto-
differentiation and immune functions. Previous experimental 
studies with alpha interferon (IFN-a) have suggested that 
modulation oftransmembrane signaling could be a critical deter-
minant in the bioregulatory diversity. To determine whether any 
initial changes at the plasma membrane would directly correlate 
with one or more actions of IFN-a, we investigated cultures of 
Daudi lymphoblasts which are uniquely susceptible to growth in-
hibition. Complementary biophysical techniques were applied. 
In one approach, changes in plasma membrane ion flux were 
measured by flow cytometry, using a fluorescent dye indicator 
of membrane potential: Cells briefly exposed (5- 10 min) to a 
DNA-recombinant 1FN-a2 (100 to 800 U/mJ) manifested a con-
sistent plasma membrane hyperpolarization (-60 to - 90 mV) 
which could be blocked by ouabain. In a second approach , 
changes in diffusion coefficients of plasma membrane-associated 
macromolecules were determined by measuring the fluorescence 
redistribution after pulse photobleaching (FRAP): Individual 
plasma membrane proteins (slgM , Leu 12 or Leu 16) were la-
belled with FITC conjugated goat antibodies [F(ab')2 or Fab'] 
or with phycoerythrin-B conjugated monoclonal mouse anti-
bodies. Statistical comparisons of cells exposed to IFN-a2 for 
10 to 30 min showed immediate 27 to 88 % increases in mean 
lateral diffusion rates. Mutant Daudi cells, cloned for resistance 
to growth inhibition showed no plasma membrane hyperpolariza-
tion with IFN-a2 (up to 1000 U/ml) , and baseline lateral diffu-
sion coefficients matched those ofIFN-a2-treated , non-resistant 
cells. We conclude that biophysical status and responses of the 
plasma membrane must be closely linked to the molecular 
mechanisms of anti-proliferative signal transduction. 
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Introduction 
The binding of a biologic regulatory molecule to its receptor 
on the plasma membrane initiates a series of transmembranous 
molecular changes which generate the signal(s) leading to biolo-
gical action (18,74). Alpha interferon (IFN-a) proteins are multi-
potent cytokines (52,65,66,79) which bind to common subsets 
of cell surface receptors (11 ,23,59). The specificity or intensity 
of signal generation by an IFN-a may be determined, to some 
extent , by receptor binding affinities (42 ,58,71); however, it is 
now widely hypothesized that the pleiotropic actions of a single 
IFN-a type are best explained by multiple signal transduction 
pathways (14,24,52). Transmembrane events after receptor bind-
ing therefore have become a critical focus for investigation 
(48,54,76). Some recent studies have implicated cytoskeletal ele-
ments (54) or inositol lipid metabolism (76) in the IFN-a signal-
ing mechanism. 
Biophysical analytic approaches afford the advantage of detect-
ing early plasma membrane changes in intact , viable cells. Using 
cells from the continuous monoclonal line of Daudi lymphoblasts 
(38) , which are exceptionally susceptible to growth inhibition 
by IFN-a (64) , we previously were able to demonstrate an early 
change in plasma membrane ion flux by measuring the redistri-
bution of fluorescent dyes sensitive to membrane potential (28). 
Measurement of fluorescence redistribution after photobleaching 
(FRAP) is another sensitive biophysical method and was devel-
oped as a means to investigate lateral diffusion either of mem-
brane-associated protein macromolecules tagged with a chromo-
phore (including receptors) or chromogenic lipid analogs (3,20, 
32 ,33,45). Typically, cells have been incubated with a fluores-
cein-coupled antibody which can be excited by photon pulses 
in the visible wave range. After thorough washing to remove 
any excess label, a spot on the plasma membrane is subjected 
to a microlaser pulse of sufficient energy to quench the fluoro-
phores without cross-linking proteins (75) or disrupting cell in-
tegrity. Recovery of fluorescence in the bleached spot depends 
upon redistribution (lateral diffusion) of labelled molecules from 
neighboring portions of the cell surface. We have employed an 
instrument system in which redistribution is sequentially mea-
sured (for up to 10 min) by an attenuated laser beam in a scanning 
mode, and lateral diffusion is calculated from equations devel-
oped for a spherical surface (40). Such measurements by FRAP 
can provide data which is complementary to studies of plasma 
membrane ion flux in transmembrane signaling (20,34,67) and 
we now report some early changes in the dynamics of Daudi 
cell plasma membranes following brief IFN-a treatments. 
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Materials and Methods 
Cell Cultures 
Monoclonal Daudi cells were derived from a Burkitt's B-cell 
lymphoma (38). A spontaneous mutant subclone (herein desig-
nated Daudi-IFr) resists growth inhibition (21,37). These cells 
were cultured as suspensions in plastic flasks using RPMI 1640 
with 25 µM HEPES buffer (Gibco, Grand Island, NY) and 10% 
NuSerum (Collaborative Research, Cambridge, MA). Log-log 
growth conditions (doubling time of24-28 h) were consistently 
maintained (28) , and uniformity of the cell cycle distribution 
was monitored by propidium iodide staining and flow cytometry 
(25,28). Previous studies have shown that cell cycle consisten-
cy is essential for reproducible expression of IFN-a receptors 
(72) and for comparison of biophysical parameters between dif-
ferent experiments (5,6,70). 
Biochemicals and Fluorescent Reagents 
Alpha-2 recombinant IFN-a (IFN-a2) was obtained from 
Schering Corp., Bloomington, NJ and ultrapure leukocyte inter-
feron was purchased from Interferon Sciences, New Brunswick, 
NJ. Aliquots were prepared from lyophilized stock by dilution 
into complete medium described above and frozen at - 70°C. 
Activity is given in anti-viral units (U) and was periodically veri-
fied with thawed samples as previously described (57). Ouabain 
was purchased from Sigma Chemical Co., St. Louis, MO. The 
negatively charged oxonol dye, bis, 1,3 dibutylbarbituric acid , 
trimethine oxonol [DiBaC4(3)] was obtained from Molecular 
Probes Inc., Eugene, OR. Concanavalin A (Con A) was obtained 
from Sigma Chemical Co. , St. Louis, MO and made up to 0.5 
mg/ml in stock solutions ; aliquots were frozen for long term 
storage at - 70°C. Goat F(ab'h , µ-chain specific anti-human 
IgM (0. 98 mg protein/ml) conjugated with FITC (absorbance 
ratio I.I) was purchased from Tago (Burlingame, CA). Mono-
valent Fab' fragments were prepared from the latter by reduction 
with 2-mercaptoethanol, followed by alkylation with iodoaceta-
mide and extensive dialysis against PBS at 4°C (7). Highly 
purified mouse monoclonal antibodies to the human B cell anti-
gens , Leu-12 and Leu-16, were obtained as standardized (25 µg 
immunoglobulin/ml) phycoerythrin-B (PE-B) conjugates from 
Becton Dickinson Monoclonals, Burlingame, CA. 
Labelling of Cells with Flourescent Antibodies 
Aliquots of 106 cells were sedimented at 300 xg for 7 min 
in 5 ml plastic tubes, transferred to 1.5 ml microtubes and washed 
xi in ice cold endotoxin-free Hanks BSS (Sigma Chemical Co., 
St. Louis, MO) with 3mM sodium azide to inhibit endocytosis 
(16). After washing, cells were resuspended in 50 µI of the same 
buffer, then incubated at 4°C after addition of labelled antibody 
(20 µI) for 30 min (anti-Leu 12 or anti-Leu 16) or 60 min (anti-
IgM fragments). Following labelling, cells were washed as above 
x2 and resuspended into 100 µI of the same buffer. Each of the 
antibodies produced a strong ring fluorescence. In some experi-
ments, 20 µI of Con A (100 µg/ml) was introduced for 5 to IO 
min after the labelling was completed. 
Membrane Potential Measurements 
Membrane potential was measured indirectly with the nega-
tively charged oxonol dye, DiBaC4(3) , which redistributes at 
the cell surface in response to altered ion fluxes. The methods 
used were previously detailed (1,28,73): cells were sedimented , 
washed (xi) with ice cold phosphate buffered saline (PBS), re-
suspended in ice cold PBS at a density of ca 25 x 106 cells/ml 
2154 
and maintained in an ice bath. For experimental testing, aliquots 
of 106 cells were prepared in a total volume of 1 ml of PBS and 
equilibrated for 5 min at ambient temperature in a sampling vial. 
IFN-a2 (100 to 1000 U/ml) was then introduced and the sample 
was incubated at ambient temperature for 6 min. In some experi-
ments, cells were pre-treated with ouabain for 1 min prior to 
addition ofIFN-a2. Lastly, the oxonol dye was added and equi-
librated for 2 min. The fluorescent intensity of cells thus tested 
remains stable for up to 10 min (see 73). IFN-a2 effects on in-
tensity of fluorescence emission were quantitated by flow cyto-
metric analysis in a Becton-Dickinson FACScan System, utilizing 
a 15mV argon ion laser tuned to 488 nm for fluorescence excita-
tion and "C 30" software for signal processing (Becton Dickin-
son, Mountain View, CA). 
Interferon treatments for FRAP 
For tests of immediate IFN-a2 effects, antibody-labelled cells 
were further incubated in buffer with IFN-a2 (800 U/106 cells, 
total volume 100 µI), and equilibrated at ambient temperature. 
For tests of delayed effects, cultures at a density of 5 x 105 
cells/ml were incubated with IFN-a2 (100 U/mJ) at 37°C for 
up to 28 h, then labelled with antibody as previously described. 
FRAP Techniques 
Work was performed at an ACAS 470 work station (Meridian 
Instruments Inc. , Okemos , MI). This is a computer controlled 
scanning laser instrument (inverted microscope) with image 
analysis programs (high speed data acquisition interface with 
80286 based computer). Samples were mounted in capillary 
microchambers fashioned from conventional glass slides and 
#1 coverslips separated by Scotch double-coated tape (#665, 3M 
Co. , St. Paul , MN). Microchambers measured approximately 
3 X22 X0.I mm (width X length X depth) and accommodated 
up to 5 µI of cell suspension which was introduced with a micro-
pipette . Chambers were charged immediately before use and 
were sealed with silicone at both edges to prevent desiccation 
and cell flow during analysis. Under these conditions, cells 
labelled with fluorescent antibodies or treated with the other 
reagents remained > 95 % viable for up to 4 h when maintained 
at 4°C or ambient temperature. Nevertheless, fresh aliquots were 
aliquoted from the original preparations after every 30 to 60 min 
to ensure freshness. Chambers were inverted on the computer 
controlled specimen stage for epi-illumination, with the #I cover-
slip contacting an x63 Zeiss Neofluor objective (N .A.1.25) 
using low fluorescence immersion oil (Type B, Cargille Labora-
tories , Cedar Grove, NJ). 
Fluorescence was excited with a 5W argon ion laser (Innova 
90- 5, Coherent Inc., Palo Alto, CA) tuned to 488 nm. Laser 
power was set at 400mW, and additional attenuation was provided 
by a 90% neutral density filter. The zero order laser beam was 
blocked by an optical light stop and a collimated first order laser 
beam of adjustable intensity was reflected into the epi-illumina-
tion path of an inverted microscope using a standard dichroic 
FITC filter cube (485/22 BP excitation filter, 510 OLP dichroic 
mirror, and 515 LP barrier filter). With the oil immersion ob-
jective, Gaussian beam diameter was < I µrn. Computer control 
of the laser beam through an acousto-optic modulator (lntraAction 
Model 80A) provided for either a low intensity "scan strength" 
to locate cells or to monitor fluorescence redistribution, or a 
high intensity "blast strength" to photobleach. Intensity values 
at each X-Y stage coordinate of a given raster scan were mea-
sured with a photomultiplier tube (Hamamatsu model 50-12) and 
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transformed into 2-D pseudo-color images or 1-D profiles of 
fluorescence emissions. Prior to each set of analyses, a 2-D low 
intensity field scan was used to locate immobilized cells which 
exhibited a uniform rim of fluorescent labelling. Spot photo-
bleaching was performed at the waist and edge of selected cells. 
A 1-D scan line and the photobleaching posi tion were set with 
a moveable cursor. FRAP was measured by a pre-selected series 
of intermittent low energy 1-D scans (5-10 second intervals) in-
cluding the full cell profile and the bleached zone. 
Redistribution rates and lateral diffusion coefficients were 
computed accord ing to a normal mode analysis for round sur-
faces developed by Koppel (40). The ACAS 470 program evalu-
ates both mobile and immobile components. Essentially, both 
the lateral diffusion constant (D) of mobile fluoroph ores, and 
the fraction of fluorophores which is mobile (recovery fraction) 
on the experimenta l time scale are derived from a mathematical 
integration of increments in fluorescence ratios , comparing in-
tensity changes both at the bleached edge and the unbleached 
surfaces. The normal mode analysis defines a quantity called 
µ. , which represents the calculated center of fluorescence for each 
normalized post-bleach scan. The immobile component causes 
µ. to decay to a constant offset from zero, and this offset is found 
by averaging theµ. values for the last 10 % of post-bleach scans. 
The computer program subtracts the offset from theµ. value for 
each recovery time point and plots the logarithm. Thus, the time 
scale must be sufficient to a llow completion of the recovery. 
A linear best fit is found, and its slope represents the rate of 
decay of the mobile component of µ. from which (D) is 
calculated. The ACAS program estimates the log of the mobile 
component ofµ. at time zero and calculates the ratio of the mobile 
component to the total µ. at time zero. Thi s is taken to be the 
mobile (recovery) fraction (R). 
FRAP measurements were performed at ambient temperatures, 
and data for each experimental category was averaged from re-
peated tests (from two to six times) with separate samples of 
cells. Up to 44 measurements were obtained in each category 
and statistical comparisons were performed by means of the stu-
dent's two tailed I-test. Measurements were not conducted on 
cell s with inappropriate label distribution , and rare cells show-
ing (R) of < 10 % or values of (D) with < 50 % confidence in-
tervals were excluded. 
Results 
Membrane Potential Change Induced by IFN-a2 and 
Effect of Ouabain 
The measurable membrane potentia l span of Daudi cell s was 
established by methods described previously (l,28) , using scaled 
concentrations of extracellular [K +] (5-140 mM). As previously 
noted with the recombinant alpha-A subtype of interferon (28), 
IFN-a2 also produced an early shift in membrane potential of 
Daudi cells in present experiments. This effect was dose related: 
plasma membrane hyperpolarization became progressively 
stronger as IFN-a2 concentrations were increased from 100 to 
800 U/ml (Fig. I) . Ouabain , a potent inhibitor of [Na +]/ [K +] 
ATPase (30,35), produced membrane depolarization of Daudi 
cells, when it was used at a concentration of 30-40 µ.M in pre-
liminary tests . At a lower concentration (15 µ.M) , ouabain pro-
duced no membrane depolarization , but protected the cells against 
IFN-a2 hyperpolarization (Fig. !) . Full protection occured only 
in the range of 100- 400 U/ml of IFN-a2. 
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Analyses of Antibody Labelled Daudi Cells by FRAP 
In preliminary work with the ACAS 470, a variety of instru-
mental settings were tested using Daudi cells labelled with FITC-
conjugated anti-IgM or with PE-B-labelled anti-Leu 12. Linear 
scans disclosed two peaks indicating that the fluorescent anti-
body was associated predominantly with the plasma membrane, 
while mean background fluorescence was usually far < 5 % (Fig. 
2). Optimal recoveries of fluorescence (usually > 60%) were 
obtained following a photobleaching pulse (0. 16 mJ) which re-
duced the fluorescence intensity from 40-70 % of its initial level 
(Figs. 2, 3). Low intensity scanning energy was calibrated at 
approximately 1-5 % of the photobleach intensity and was optim-
ized prior to each set of measurements by performing a series 
of prescans for up to twice the expected duration of the experi-
ment. Using a pilot specimen the scan beam strength was ad-
justed to a level which caused well under 5 % photobleaching. 
Under these conditions,µ. graph recoveries of Daudi cells were 
reproducibly asymptotic (carried to complet ion), between 400 
to 500 sec (Figs. 4, 5). Post-recovery integri ty of the cell s was 
shown by repeated bleachings and dye viability tests. 
The nature of the FRAP technique requires use of antibody 
probes, such as anti-sigM, which may of themselves introduce 
changes in the membrane fluid dynamics (49,56). For compara-
tive studies, we therefore analyzed 3 different plasma membrane 
antigens (Table !): slgM, Leu-12 and Leu-16. Antibodies specific 
for IgM µ. -chain included both the F(ab'h and Fab' fragments. 
Individual diffusion coefficients (D) for each of the antigens 
monitored (Table 2) were within a range of 5.3 to 7.7 x 10 - 10 
cm2/sec, with mean recovery fractions (R) in a range of 45-
80 % (Table 2). Both ranges matched previous FRAP data relat-
ing to lymphocyte surface proteins (5,16,19,31,44) . There was 
no obvious correlat ion of (D) with several fo ld differences in 
antigen molecular weights, antibody fragment size or either of 
the two different fluorophore conjugates (Table I) . In accord 
with some recent data (5); however, the mean diffusion rate of 
the Daudi cell slgM labelled with FITC-Fab' fragments was 33% 
higher (p < 0.01) than the mean diffusion rate of slgM reacted 
with F(ab')2 . 
The work with PE-B as a flu orophore for FRAP was new, 
but proved advantageous: the fluorescent yield at 488 nm is 
several fold higher than for an equivalent fluorescein label (51,69) 
and the PE-B molecules are more stable than fluorescein dur-
ing photon bombardment (69). Preliminary direct comparison 
of FITC-labelled anti-Leu-12 and PE-B-labelled anti-Leu 12 
showed similar lateral mobilities of the Leu 12 antigen , and 
results with an Fab' PE-B anti-kappa chain were si milar to the 
results with Fab' FITC-anti-µ. chain (Balint E, Grimley PM , un-
published data). 
Analyses of IFN-a2-Treated Daudi Cells by FRAP 
FITC-antibody or PE-B-antibody labelled Daudi cells were 
incubated with IFN-a2 or with polyvalent unlabelled Con A 
as a "treatment control". With all test antigens, treatment with 
IFN-a2, for periods of up to 30 min, significantly increased 
the mean (D), with a range of 7.9 to ll x I0 - 10 cm2/sec (Table 
2). In preliminary tests of Daudi cells pretreated with IFN-a2 
for 28 h, (D) for sigM was also increased (not shown). In con-
trast , Con A consistently decreased the mean (D) , with a range 
from 4.0 to 6.1 x I0 - 10cm2/sec. Previous data indicated that 
Con A should decrease latera l mobility of plasma membrane 
proteins (29,47,78). Changes in mobile fraction s (R) sometimes 
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Scanning Distance (1Pt = 0.25 11m) 
Fig. 2. Low intensity fluorescent scans of a Daudi lympho-
blast labelled with FITC-conjugated anti-lgM Fab' show-
ing fluorescence intensity (arbitrary units) vs. distance 
scanned by the laser (points at 0.25 µm intervals). a) Aver-
age of three linear scans (Scans 1-3) before the photobleach-
ing pulse. Edge peaks and waist diameter of the cells (ca 
15 µm) are typical. b) First scan (Scan 4), 10 sec after photo-
bleaching (67%), note stable flourescence intensity at un-
bleached rim of cell. 
Fig. 1. Shifts of Daudi cell membrane potential calculated 
in mV (-55 to -90 mV), related to increasing concentra-
tions of IFN-a2 (U/ml). Point marked as solid diamond (at 
-55mV) shows protective effect of ISµm ouabain when added 
before IFN-a2 (400 U/ml) . 
Table 1. Molecular weights of antibodies, fluorophores and 
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Leu 12 95 ,000 
Leu 16 35 ,000 
Scan 28 
10 20 30 40 50 60 70 80 90 100 
Scanning Distance (1 Pt = 0.25 11m) 
Fig. 3. Scan 28 (c) at 464 sec after photobleaching (the iden-
tical cell and same units as in Fig. 2). The essentially com-
pleted recovery fraction (R) was 96% (calculation explained 
in Materials and Methods). A decreased fluorescence inten-
sity of the opposite edge of the cell is probably due to com-
bined effects of dye redistribution and minimal bleaching 
( < 5%) by the repetitious post-bleach scans. The normal 
mode analysis for round cells (40) compares both cell edges 
and thus compensates for these changes both in the com-
putations of (R) and the lateral mobility (D). 
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Fig. 4. ACAS 470 plot ofµ vs. time (seconds), after photo-
bleaching of the identical cell scanned in Fig. 2, according 
to the normal-mode analysis of spherical cells (40) in which 
µ represents the center of fluorescence (see Materials and 
Methods). 
Fig. 5. ACAS 470 regression plot of In µ vs. time (seconds), 
after correction for the µ offset (analysis of same cell as Figs. 
2-4, see Materials and Methods). The computation for (D) 
was 7.14xI0 - 10cm2/sec (correlation 0.96). 
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paralleled the changes in D and in two instances data were 
statistically significant: a) there was an increased (R) after in-
cubation of FITC-anti-IgM F(ab')z-labelled cells with IFN-cx2 
(p <0.02), and b) there was a decreased (R) after incubation 
of FITC-anti-IgM F(ab')z or PE-B-anti-Leu 12 labelled cells 
with Con A (p < 0.02). 
Comparative Analyses of Daudi-IFr Cells 
In view of the above findings , it became of interest to com-
pare FRAP results with a mutant subclone of Daudi cells (Daudi-
IFr) known to resist the antiproliferative action of alpha inter-
ferons and the concomitant suppression of c-myc oncogene ac-
tivity (37). We have found that Daudi-IFr cells behave similarly 
to other alpha interferon resistant Daudi clones (17,26,64,72) by 
remaining sensitive to induction of 2.:.y adenylate synthetase, 
and to inhibition of thymidine kinase (Grimley PM , Walsh D, 
Rupp B, unpublished data). Previously, we had shown that 
Daudi-IFr cells resisted the membrane potential changes induced 
by type A alpha interferon (28). The latter was reconfirmed, using 
Daudi-IFr cells which were continuously maintained in 1000 
U/rnJ of ultrapure leukocyte interferon or treated once a week 
with 100 U/ml. Under either of these maintenance conditions, 
plasma membranes of the Daudi-IFr cells did not hyperpolarize 
when incubated with 100 U/ml of DNA-recombinant IFN-cx2. 
They only partially lost resistance after growth for two weeks 
( > 8 mass doublings) in medium without interferon , and simul-
taneously became susceptible to hyperpolarization (Aszalos A , 
Grimley PM , unpublished data). 
In FRAP experiments, preliminary data with PE-B-anti -Leu 
16 labelled cells indicated that (D) values in Daudi-!Fr cells were 
very close to the values previously observed in their parental 
Daudi-IFs cells after IFN-cx2 treatment. The mean (D) value 
for control Daudi-IFr cells in log-log growth was 
9.4 ± I.0xJ0 - 10 cm2/sec (II measurements) and after IFN-cx2 
was essentially unchanged (8.7 ±0.8 x J0 - 10 cm2/sec). The signi-
ficance of these (D) values compared to (D) values for Daudi-
IFs cells was p < 0.001 (see Table I). These higher (D) values 
in PE-B-anti-Leu 16 labelled Daudi-!Fr cells were observed for 
up to one week after removal of leukocyte interferon from the 
maintenance growth media, during which time there had been 
at least four mass doublings. 
Discussion 
Effects of IFN-cx2 on the cell genome and biosynthetic path-
ways are very rapid. New messages begin to appear within 10 
min and their transcription may peak at I to 2 h (41). Thus, 
the experimental window for exploring primary effects of IFN-
cx2 at the receptor and post-receptor levels are narrow. Non-
disruptive biophysical measurements may offer the best oppor-
tunity to observe rapid plasma membrane changes which ap-
proximate primary signaling events. The methods of membrane 
potential measurement and FRAP which we have tested obvious-
ly require several minutes of cell preparation , but can be 
promptly deployed. Evidence that alpha interferon signals are 
short-lived (4), and that alpha interferon , attached to its recep-
tors, cumu latively stimulates cells (4,61,68) , lends further cre-
dence to these measurements. Other studies (8,10) including elec-
tron spin resonance (53), also have suggested changes in the 
plasma membrane environment after alpha interferon treatment. 
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Present results with ouabain and our previous studies with 
channel blocking drugs (2) , indicate that the early membrane 
potential changes induced by alpha interferons are related to 
[K +] flux changes. The biological significance of [K +] flux 
changes through the plasma membrane is well documented. 
Alteration of [K +] fluxes across the plasma membrane of lym-
phocytes is the earliest event related to the function of the im-
munosuppressive agent cyclosporin A (15) and [K +] channel 
blockers selectively inhibit IL-2 mRNA formation (9) and pre-
vent functions of NK cells (63). Signaling through opiate recep-
tors (50) and serotonin receptors (13) also is intimately connected 
to modulation of [K +] fluxes. Thus, the alpha interferon effect 
is consistent with that of several other potent cytokines or bio-
regulators. 
The (D) values Daudi cell surface antigens tested by FRAP 
in our experiments were comparable to data previously published 
for lymphocytes (5,16) and fell into an "intermediate" range (46). 
As shown in Table I, the extreme molecular weights for com-
plexes of plasma membrane antigens, antibody molecules and 
fluorophores in our experiments was up to threefold: i.e. , the 
mass of anti-Leu 16/ PE-B plus Leu-16 complex (ca 420,000) 
would be approximately one third the mass of anti-IgM-F(ab')z-
FITC plus slgM complex (ca 1,300,000). In each case, however, 
(D) was remarkably similar. We surmise that the observed in-
crease in mobility of slgM complexed with FITC-Fab' fragments , 
as compared to FITC-F(ab')z antibody (Table I), is more like-
ly related to reduced cross- linking between sigM molecules 
labelled with an Fab' fragment (5) than to differences in the total 
weight of the antigen/antibody complexes (70). Macromolecular 
cross-linking (78) and increased membrane occupancy (29) are 
factors in retarding lateral mobility and Con A is known to 
restrict lateral mobility both of surface lectin receptors (47,78) 
and immunoglobulins (29) . The latter evidently reflects interac-
tions propagated through the cytoskeleton (29). Although rela-
tively small, the effects of Con A noted in our experiments were 
reproducible and in a consistently opposite direction of IFN-
cx2 (Table I). 
The increased (D) of several plasma membrane antigens im-
mediately after IFN-cx2 treatment was reproducible and indicates 
a swift reduction of protein mobility constraints. While several 
previous reports , including studies of cell fusion and of cappi ng 
of sigM have suggested a "decreased fluidity" of the plasma mem-
brane after interferon treatment (8,12,53,55,58), the latter obser-
vations are not necessarily inconsistent with our FRAP results. 
At least two interdependent levels of molecular constraint must 
be distinguished: a) effects of ligands on the cytoskeleton or on 
receptor-cytoskeletal intractions (1,55) and b) direct effects on 
the surface membrane molecular environment (28,39,45). In 
other systems, lateral diffusion was influenced by steric or charge 
interactions (22,29,39,60) and recent FRAP studies indicate that 
configuration of surface proteins in the ectodomain (43,56,62,70) 
and distribution of macroscopic domains (77) may be interactive 
determinants of (D). 
In Daudi-IFr cells, the resistance to the growth inhibitory 
effect of alpha interferons was associated with an increased 
lateral diffusion , that is the same direction as found in the 
IFN-cx2-treated Daudi-!Fs cells. Furthermore, the results in-
dicated an "imprint" of alpha interferon , even when Daudi-!Fr 
cells were maintained in medium without interferon. While these 
parallel findings are not yet explained, they do suggest that 
Lymphoblast Membranes and Interferon 
resistance to IFN-a is entirely or partially controlled by modu-
lation of early signal transduction with a consequent alteration 
of the physiolog ic response (36) . 
In view of the effects of IFN-a2 on [K + ] flux discussed above 
and earlier observations of an altered electrophoretic charge on 
interferon-treated mouse cells (39) , the IFN-a2-induced changes 
in lateral diffusion rates could be related to an altered transmem-
brane potential or ion flux. It must be recognized that the effects 
of such plasma membrane biophysical changes on membrane 
associated protei n configuration or functional activity may be 
complex (Tl) , so that the results of our experimental measure-
ments with IFN-a2 cannot yet be definitively interpreted at a 
mechani stic level; nevertheless, the possibility that accelerated 
diffusion of interferon receptors may promote physiologic linkage 
to immobile [K +] channels (cf.34,67) is most intriguing. 
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Discussion with Reviewers 
Reviewer III: It is extremely important that the investigators 
demonstrate that geometric influences are not reflected in the 
small differences they observe following IFN-a2 treatment. 
Authors: During the short exposures to IFN-a2, cell size does 
not change significantly, as shown by comparing the 90° light 
scatter in flow cytometric studies (text reference 28). Only longer 
exposures to IFN-a influence the cell and cell sizes (text refer-
ence 64), and must be compared to other controls for these ef-
fects. Surface ruffling of neoplastic lymphocytes treated by IFN-
a has been reported (Garnliel H , Hiraoka A, Golomb HM , The 
effect of cultivation and interferon treatment on the surface mor-
phology of hairy cell leukemia cells, Cancer Invest. 5, 389-399, 
1987), but topology may reflect as well as determine changes 
in the fluid-molecular dynamics (27) . The 2-3 fold differences 
in (D) values between IFN-a2 and control cells were statistically 
significant. (Text table 1) and consistently increased with each 
probe. Similarly small differences have been noted in other sys-
tems (Magnusson K-E , Wojcieszyn J, Dahlgren C, Stendahl 0, 
Sundquist T, Jacobson K, Lateral diffusion of wheat germ 
agglutinin-labelled glycoconjugates in the membrane of differen-
tiating HL-60 and U-937 cells assessed with fluorescence reco-
very after photobleaching, Cell Biophys. 5, 119- 128, 1983; and 
Yechiel E, Barenholz Y, Henis YI , Lateral mobility and organi-
zation of phospholipids and proteins in rat myocyte membranes. 
Effects of aging and manipulation of lipid composition, J. Biol. 
Chem. 260, 9132-9136, 1985). The ultimate test of biologic sig-
nificance lies in the comparison of Daudi-IFs and Daudi-IFr. 
These cells have similar doubling kinetics and cannot be dis-
tinguished by size during log-log growth. 
C.F. Hazlewood: In view of our knowledge of transmembrane 
proteins with intracellular anchoring as well as the significant 
protein associations with surface proteins, how can we be cer-
tain that the FRAP experiments measure lateral diffusion? ls 
this true diffusion or simply the rearrangement of proteins with 
intracellular connections? 
Authors: These basic questions regarding FRAP measurements 
have been addressed in many experiments (text references 31, 
33, 42-45, 56, 62). Constraints upon free lateral diffusion of 
proteins in the surface membrane appear to be governed pri-
marily by factors in the ectodomain rather than by any intra-
cellular connections or energy-dependent anchorage modulation. 
E. Balint, A. Aszalos, P.S. Pine and P.M. Grimley 
H. Gamliel: The results are intriguing, but it is not clear enough 
as to why the observed increase in lateral diffusion of membrane 
molecules does not contradict other reports on decreased fluidity 
of the membrane and impairment of receptor rearrangement after 
interferon. 
Authors: Several important differences must be considered: I) 
Contraction of the cytoskeleton or membrane movements can 
be directly involved in the capping process (Schmit AJ, Pagano 
RE , Capping of a phospholipid analog in the plasma membrane 
of lymphocytes, Cell 23, 105-112 , 1981) , whereas lateral diffu-
sion can be independent of anchorage modulation (text references 
42-45, 62). 2) Our experiments measured changes at < 30 min 
compared to some previous work which showed impairment of 
capping at 3 to 6 h (text reference 55). 3) Although IFN-a even-
tually does apear to increase cytoskeletal rigidity (text reference 
52), our experiments now show that IFN-a2 does not act like 
Con A on lateral diffusion constraints: Con A can cross-link 
receptors to the cytoskeleton and cause secondary effects on ad-
jacent molecules (text references 29, 78). 4) Electron spin re-
sonance measurements have suggested decreased fluidity of the 
lipid phase in interferon-treated cells (text reference 53), but 
this technique measures rotational movements of an introduced 
probe rather than lateral translation of endogenous membrane 
proteins. The membrane molecular environment is very complex 
(text references 33, 45, 60) and FRAP measures only one di-
mension of the total dynamics (see Lands WEM , Davis FS, De-
finitions, explanations, and an overview of membrane fluidity, 
In Aloia RC (ed.) , Membrane Fluidity in Biology, Vol. 2. Aca-
demic Press, Orlando, FL., pp. 1-4, 1983) . Previous studies 
have illustrated that diffusion of lipids and proteins may be in-
dependently modulated (text reference 56, De Laat SW, Yan der 
Saag PT, Elson EL, Schlessinger J, Lateral diffusion of mem-
brane lipids and proteins during the cell cycle of neuroblastoma 
cells. Proc. Natl Acad. Sci. USA 77, 1526- 1528, 1980) . 
Reviewer III: Modulation of lateral diffusion following Con 
A addition did not reflect the magnitude of changes observed 
by others, namely 5 to IO-fold decreases in lateral mobility. 
Authors: This is true. We cannot explain why greater quantita-
tive differences were not observed, even with high concentrations 
of Con A (100 µg/ml), but differences in anchorage modulation 
have been noted by others (text reference 78). Since Daudi cells 
are neoplastic, the cytoskeletal matrix may be differently con-
figured than in normal lymphocytes which respond more drama-
tically (text reference 29). More recently we increased the Con 
A incubation time from 5-10 min to 30 min . We then obtained 
up to 3-fold differences after IFN-a2 treatment. 
H. Gamliel: Since cells undergoing antibody-antigen reactions 
or receptor-ligand conjugation tend to rearrange their surface 
components (i.e., patching, capping), don't you agree that these 
events preceding IFN-a2 treatment could impact the reliability 
of subsequent measurements? How can you relate the observa-
tions to IFN-a2 itself rather than to IFN-a2 plus events trig-
gered beforehand? 
Authors: Because it is essential to label proteins with chromo-
genic ligands for FRAP measurements, this technique obviously 
cannot determine how the presence of a labeled probe per se 
alters the intrinsic diffusion coefficient of a given surface anti-
gen . For this reason FRAP data can only be interpreted relative 
to other biologic systems and controls. We labelled the cells at 
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4°C, then added IFN-a2 at ambient temperature. During a limited 
time of examination (30 min) more than 90 % of cells showed 
a ring fluorescence . There was only minimal patching in scat-
tered cells, and FRAP measurements could be repeated on the 
same cell without induction of capping. 
H. Gamliel: Sodium azide is a well known stabilizer of mem-
brane components, utilized for preventing rearrangement of the 
surface receptors following interaction with ligands. How then 
could you correctly determine the effect of IFN-a2 on your 
measurements? 
Authors: As discussed above, the relation of lateral diffusion 
measurements to capping and patching dynamics is complex. 
In contrast to capping, lateral diffusion measured at room tem-
perature or in the presence of Na azide is not energy depen-
dent and does not involve cytoskeletal propagation (see text refer-
ences 16, 29, 45, 56, 62). 
H. Gamliel: Most of your measurements were done on cells 
which were first labeled and then treated with IFN-a2. This 
is different from other systems where analysis was done on cells 
which are first treated with IFN and then labelled or stained. 
Why did you prefer labelling cells with antibody prior to incu-
bation with IFN-a2? 
Authors: We chose to pre-label, since the effect of!FN-a2 on 
membrane dynamic occurs within 10 min and the antibody 
labelling steps, including washes, require > 30 min. 
H. Gamliel: It is not clear why probes for Leu-12 and Leu-16 
were selected for these studies or why reagents against recep-
tors other than IgM were not tested . 
Authors: Reactions of a number of commercially available chro-
mophore-labelled monospecific or monoclonal antisera with 
Daudi cells were tested. Of the FITC-coupled reagents , only 
anti-IgM produced a sufficient intensity for FRAP analyses; 
however, some commercially available PE-conjugates afforded 
higher fluorescent yields. We empirically chose Leu 12 and Leu 
16 surface antigens which differ in molecular weights; however, 
preliminary tests with anti-Leu 8 and anti-CALLA gave similar 
(D) values. Daudi cells lack surface HLA antigens and beta 
microglobulin. 
H. Gamliel: In order to enhance labeling with antibodies, re-
searchers prefer the indirect labeling methods which amplify 
the staining intensity. Could you elaborate on what might be 
the extent of differences in measurements if receptors/antigens 
are labelled indirectly, i.e. , by using primary antibody followed 
by FITC-tagged secondary antibody? Do such longer complexes 
resemble lgM in their lateral diffusion coefficients? 
Authors: Findings in text reference 5 indicate that the effect 
of size of a given receptor antibody complex on the diffusion 
coefficient appears to be less than the effects of cross-linking 
between surface molecules. Our data with PE-B label confirms 
that relatively large probe-protein complexes can diffuse in the 
range of 5 x 10 - 10cm2/sec. Indirect labelling would probably 
decrease lateral diffusion only to the extent that cross-linking 
were introduced. 
C.F. Hazlewood: I am quite certain that the dye used in this 
paper is in some way related to the cellular potential ; however 
most dyes used to determine the "membrane potential" are bound 
to cellular constituents (see Wilson HA , Seligmann BE, Chused 
Lymphoblast Membranes and Interferon 
TM, Voltage sensitive cyanine dye fluorescence signals in lym-
phocytes: plasma membrane and mitochondrial components. J. 
Cell Physiol. , US, 61-71, 1985). How, therefore can one use 
the Nernst equation which is derived from dilute solution theory 
(73) to estimate membrane potential? Please also refer to Ncgen-
dank W, Ion and water retention by permeabilized cells, Bio-
chim. Biophys. Acta , 694, 123-161 , 1982 and Ling , GN, Elec-
trical potentials , In: In Search of the Physical Basis of Life, 
Plenum Press, pp. 477- 494, 1984. 
Authors: The oxonol dye which we used was introduced as a 
superior method for detecting membrane potential (text reference 
73). Such dyes do dissolve into the membrane lipid domain and 
therefore they truly reflect the [K + ]-driven membrane poten-
tial which can be described by the Nernst equation. Related 
references on the use of these dyes for membrane potential mea-
surements include: Waggoner AS, Wang CH, Tolles RL , Me-
chanism of potential-dependent light absorption changes of lipid 
bilayer membranes in the presence of cyanine and oxonol dyes. 
J. Membr. Biol., 33, 109-140, 1977; Rink TF, Montecucco C, 
Hesketh TR, Tsien RY, Lymphocyte membrane potential as-
sessed with fluorescent probes, Biochem. Biophys. Acta , 595, 
15-30, 1980; Brauner T, Hulsere OF, Strasser RJ, Comparative 
measurements of membrane potentials with microelectrodes and 
voltage-sensitive dyes, Biochim . Biophys. Acta , 771, 208- 246, 
1984. 
C.F. Hazlewood: The effect of IFN-a2 on the cellular potential 
(Fig. I) is remarkable and most interesting. ls it possible that 
the potential is a surface adsorption potential rather than a mem-
brane potential? The use of some surface or phase boundary 
theory might be helpful in overcoming the problems of dye ad-
sorption within the cell. 
Authors: We recognize that different intracellular compartments 
(e.g. , Hazlewood CF, Kellermayer M , Ion and water retention 
by permeabilized cells, Scanning Microsc. 2, 257-273, 1988) 
may have their own potentials which are distinct from the plasma 
membrane potential; however, oxonol dye measurements do not 
reflect any potential , other than that of the plasma membrane 
(text reference 73). In lymphocytes only [K+] fluxes influence 
membrane potential in the range which we measure (i.e. , circa 
- 55 mV). Thus, our data are logically interpreted as reflecting 
the effect of IFN-a2 binding on transmembrane [K +] fluxes. 
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